A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.

MLA

Zelmer A, et al. “A New in Vivo Model to Test Anti-Tuberculosis Drugs Using Fluorescence Imaging.” Journal of Antimicrobial Chemotherapy (JAC), vol. 67, no. 8, Aug. 2012, pp. 1948–60. EBSCOhost, https://doi.org/10.1093/jac/dks161.

APA

Zelmer A, Carroll P, Andreu N, Hagens K, Mahlo J, Redinger N, Robertson BD, Wiles S, Ward TH, Parish T, Ripoll J, Bancroft GJ, Schaible UE, Zelmer, A., Carroll, P., Andreu, N., Hagens, K., Mahlo, J., Redinger, N., & Robertson, B. D. (2012). A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. Journal of Antimicrobial Chemotherapy (JAC), 67(8), 1948–1960. https://doi.org/10.1093/jac/dks161

Chicago

Zelmer A, Carroll P, Andreu N, Hagens K, Mahlo J, Redinger N, Robertson BD, et al. 2012. “A New in Vivo Model to Test Anti-Tuberculosis Drugs Using Fluorescence Imaging.” Journal of Antimicrobial Chemotherapy (JAC) 67 (8): 1948–60. doi:10.1093/jac/dks161.